Search Daily Report

Global Health Events

Calendar
Upcoming Events List
  • Ending Poverty and Hunger: Meeting the Challenge of Millennium Development Goal 1 11/24
  • The Global Food Crisis: "The Silent Tsunami" The Brookings Institutions "will host a discussion on nutrition, school feeding programs and food security in the developing world, featuring World Bank Group President Robert B. Zoellick; Josette Sheeran, executive director of the United Nations World Food Programme; and Samuel Worthington, president and CEO of InterAction." 11/24
  • A Call to Copenhagen – Health Effects of Climate Change "Members of the press are invited to the unveiling and policy discussion of a major international study on the Public Health Impacts of Reducing Greenhouse Gas Emissions being published in Lancet, just in time for the upcoming United Nations Climate Change Conference in Copenhagen. The National Institute of Environmental Health Sciences (NIEHS), one of the National Institutes of Health, is sponsoring the event which will feature speakers from around the world gathered in Washington, DC and at the London School of Hygiene and Tropical Medicine participating via live video conferencing." 11/25

AP/Washington Post Examines Experimental Malaria Vaccine, Mutant Mosquitoes To Combat Malaria

Toolbox

Tuesday, June 09, 2009

The AP/Washington Post examines attempts to create a live vaccine and mutant mosquitoes to fight malaria.

During the 1990s, Sanaria CEO Stephen Hoffman "irradiated malaria-carrying mosquitoes to weaken the parasites inside them, and he and 13 colleagues subjected themselves to more than 1,000 bites," according to the AP/Washington Post. "Usually malaria parasites race to the liver and multiply before invading the bloodstream" and making their host sick, but these "weakened parasites" sat "harmlessly in the liver, unable to multiply but triggering the immune system to fend off later infections," the AP/Washington Post reports, adding that only one of the people in Hoffman's test did not achieve immunity "when bitten by regular malaria-infected mosquitoes over the next 10 months."

Hoffman said critics charged that turning his experiment into a vaccine was almost impossible and that he was "dismissed by 99 percent of the people in the malaria field." But, two weeks ago about 100 volunteers started receiving doses of Sanaria's vaccine in a first-stage FDA-approved study.

Aside from a vaccine, about "a dozen labs worldwide" are trying to combat malaria by breeding malaria-resistant mosquitoes, the AP/Washington Post reports. David O'Brochta's lab at the University of Maryland is working on ways to enable mosquitos to pass on malaria parasite resistance to their offspring, according to the AP/Washington Post. To be effective, "a malaria-resistance gene would have to spread a lot faster through mosquito populations," as a result the O'Brochta lab's main focus is how to speed that up.

Sanaria is working on a mosquito that can harbor double the number of immature parasites, to facilitate harvesting the parasites for the vaccine. O'Brochta is working on something similar and is trying to switch off a gene that protects the mosquito when it eats malaria-infected human blood. However, O'Brochta said, "No one has ever made transgenic mosquitoes with this gene knocked out," adding, "We want to cripple its immune system so when it takes an infected meal, it gets infected at very high levels" (Neergaard, AP/Washington Post, 6/8).